| Patient |
Target Disorder and Reference Standard |
Diagnostic Test |
LR+
(95% CI)
|
Post-test Probability |
LR-
(95% CI)
|
Post-test Probability |
suspected H. pylori infection c

(pre-test probability: 65%) |
H.pylori infection (4 concordant tests) |
CLO test |
infinity (29 to infinity) |
100% |
0.10 (0.067 to 0.16) |
16% |
| |
|
acute antral inflammation |
0.14 (6.2 to 30) |
96% |
14 (0.097 to 0.21) |
21% |
| |
|
chronic antral inflammation |
3.0 (2.2 to 3.9) |
84% |
0.0 (0.0 to 0.026) |
0% |
| |
|
Warthin-Starry stain |
88 (13 to 620) |
99% |
0.07 (0.041 to 0.12) |
11% |
suspected H. pylori infection a

(pre-test probability: 48%) |
H.pylori infection (histology) |
Giemsa stain |
25 (3.6 to 170) |
96% |
0.043 (0.0064 to 0.30) |
4% |
dyspepsia and suspected H. pylori infection a

(pre-test probability: 35%) |
H.pylori infection (histology + CLO test) |
urease breath test |
14
(6.2 to 30) |
88% |
0.091
(0.036 to 0.23) |
5% |
suspected H. pylori infection c

(pre-test probability: 65%) |
H.pylori infection (4 concordant tests) |
serum IgG |
11 (5.6 to 21) |
95% |
0.095 (0.058 to 0.15) |
15% |
| |
|
serum IgA |
4.8 (3.0 to 7.9) |
90% |
0.34 (0.26 to 0.43) |
38% |
undergoing upper GI endoscopy c

(pre-test probability: 62%) |
H.pylori infection (2 positive from histology, culture, rapid urease breath test) |
stool immunoassay |
12 (4.9 to 32) |
92% |
0.043 (0.011 to 0.17) |
4% |
dyspepsia and suspected H. pylori infection a

(pre-test probability: 35%) |
H.pylori infection (histology + CLO test) |
ELISA |
9.3
(5.0 to 17) |
83% |
0.071
(0.024 to 0.21) |
4% |